Inventor · disambiguated record
Lars Thoresen
Also filed as: THORESEN LARS HENRIK · THORESEN Lars
15 granted patents·11 pending applications·204 citations·filing 2000–2021
94Inventor score
Top patents by PatentIndex Score
26 records- 0196US11771695B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Oct 3, 2023·4 cites·11 claims
- 0295US6495541B1Tricyclic inhibitors of poly(ADP-ribose) polymerasesAGOURON PHARMA·Filed 2000·Granted Dec 17, 2002·76 cites·5 claims
- 0394US8778950B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2010·Granted Jul 15, 2014·21 cites·6 claims
- 0494US8415484B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Apr 9, 2013·29 cites·48 claims
- 0592US11214548B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Granted Jan 4, 2022·3 cites·8 claims
- 0692US10632134B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Granted Apr 28, 2020·5 cites·16 claims
- 0791US9867822B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 16, 2018·7 cites·18 claims
- 0891US9492447B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2015·Granted Nov 15, 2016·9 cites·20 claims
- 0991US7429578B2Tricyclic inhibitors of poly(ADP-ribose) polymerasesAGOURON PHARMA·Filed 2005·Granted Sep 30, 2008·16 cites·5 claims
- 1088US9597340B2Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Granted Mar 21, 2017·9 cites·17 claims
- 1185US9108969B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Aug 18, 2015·6 cites·33 claims
- 1284US6977298B2Tricyclic inhibitors of poly(ADP-ribose) polymerasesCANCER RES CAMPAIGN TECH·Filed 2004·Granted Dec 20, 2005·16 cites·8 claims
- 1381US9944606B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2012·Granted Apr 17, 2018·3 cites·30 claims
- 1477US2022306586A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Application pending·0 cites
- 1574US11746091B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Sep 5, 2023·0 cites·12 claims
- 1667US2020069681A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Application pending·0 cites
- 1764US12109219B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Oct 8, 2024·0 cites·20 claims
- 1864US2018354907A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2018·Application pending·0 cites
- 1963US2018280386A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Application pending·0 cites
- 2055US2014206649A1Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Application pending·0 cites
- 2152US2003078254A1Tricyclic inhibitors of poly(ADP-ribose) polymerasesFiled 2002·Application pending·0 cites
- 2249US2010292233A1Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonistsARENA PHARM INC·Filed 2009·Application pending·0 cites
- 2349US2010273806A1Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2008·Application pending·0 cites
- 2448US2015336966A1Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Application pending·0 cites
- 2542US2014018371A1Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related TheretoJONES ROBERT M·Filed 2012·Application pending·0 cites
- 2637US2008070867A12-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine PhosphatasesMETABASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Thoresen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →